Furthmore, Yu et al. showed PPARγ preventd DEN-induced HCC using a PPARγ-deficiency mouse model, which served as a solid evidence for our results and suggested the significant role of DR in inhibiting HCC57. This evidence concerns the gene PPARG and hepatocellular carcinoma.